Literature DB >> 20736802

Negative pressure wound therapy reduces pseudomonas wound contamination more than Staphylococcus aureus.

Steven J Lalliss1, Daniel J Stinner, Scott M Waterman, Joanna G Branstetter, Brendan D Masini, Joseph C Wenke.   

Abstract

PURPOSE: The purpose of this study is to determine if negative pressure wound therapy (NPWT) treatment results in fewer bacteria than wet-to-dry (WTD) dressings in a contaminated open fracture wound model.
METHODS: For Study 1, complex wounds were created on the proximal left leg of goats. The wounds were inoculated with Pseudomonas aeruginosa. The wounds were débrided and irrigated 6 hours after inoculation. The first group received WTD dressing changes twice daily; the second and third groups received NPWT using systems from two different companies. All three groups received repeat débridements every 48 hours for 6 days. Bacteria quantification was performed both immediately before and after each débridement. For Study 2, the only changes were that Staphylococcus aureus was used and only one NPWT group was included.
RESULTS: In Study 1, there were significantly fewer Pseudomonas in both NPWT groups at all imaging sessions after the initial débridement and irrigation. At the 6-day time point, the wounds in the NPWT groups were 43 +/- 14% and 68 +/- 6% of the baseline amount, respectively. The WTD groups were 464 +/- 102% of the baseline amount. In Study 2, NPWT did not reduce the S. aureus contamination within the wound. At the 6-day time point, the wounds in the NPWT and WTD groups contained 115 +/- 19% and 192 +/- 52% of the baseline values, respectively.
CONCLUSION: NPWT showed a significant and sustained decrease in the Pseudomonas levels compared with WTD dressings at all time points. This beneficial effect was seen not seen in S. aureus.

Entities:  

Mesh:

Year:  2010        PMID: 20736802     DOI: 10.1097/BOT.0b013e3181ec45ba

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  24 in total

Review 1.  Infected animal models for tissue engineering.

Authors:  Alexander M Tatara; Sarita R Shah; Carissa E Livingston; Antonios G Mikos
Journal:  Methods       Date:  2015-04-02       Impact factor: 3.608

Review 2.  Antibiotic-laden PMMA bead chains for the prevention of infection in compound fractures: current state of the art.

Authors:  David Seligson; Stephen Berling
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-06-09

Review 3.  The Effect of Vacuum-Assisted Closure on the Bacterial Load and Type of Bacteria: A Systematic Review.

Authors:  Aryan S P Patmo; Pieta Krijnen; Wim E Tuinebreijer; Roelf S Breederveld
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-05-01       Impact factor: 4.730

4.  [Toxic shock syndrome after open ankle fracture].

Authors:  T Klüter; S Fitschen-Oestern; M Weuster; H Fickenscher; A Seekamp; S Lippross
Journal:  Unfallchirurg       Date:  2015-07       Impact factor: 1.000

5.  Ten-year analyses of the German DRG data about negative pressure wound therapy.

Authors:  Olga von Beckerath; Alexander Zapenko; Joachim Dissemond; Knut Kröger
Journal:  Int Wound J       Date:  2016-07-04       Impact factor: 3.315

6.  Impact of negative-pressure wound therapy on bacterial behaviour and bioburden in a contaminated full-thickness wound.

Authors:  Zhirui Li; Qingwen Yu; Song Wang; Guoqi Wang; Tongtong Li; Pei-Fu Tang; Daohong Liu
Journal:  Int Wound J       Date:  2019-09-04       Impact factor: 3.315

7.  A Unique Application of Negative Pressure Wound Therapy Used to Facilitate Patient Engagement in the Amputation Recovery Process.

Authors:  Jessica Wise; Alicia White; Daniel J Stinner; John R Fergason
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-08-01       Impact factor: 4.730

8.  Measurement of vancomycin hydrochloride concentration in the exudate from wounds receiving negative pressure wound therapy: a pilot study.

Authors:  Yukiko Ida; Hajime Matsumura; Masami Onishi; Sayaka Ono; Ryutaro Imai; Katsueki Watanabe
Journal:  Int Wound J       Date:  2014-03-28       Impact factor: 3.315

9.  Wound Penetration of Cefazolin, Ciprofloxacin, Piperacillin, Tazobactam, and Vancomycin During Negative Pressure Wound Therapy.

Authors:  Matthew P Rowan; Krista L Niece; Julie A Rizzo; Kevin S Akers
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-02-01       Impact factor: 4.730

Review 10.  Retained Negative Pressure Wound Therapy Foams as a Cause of Infection Persistence.

Authors:  Konstantinos Anagnostakos; Andreas Thiery; Ismail Sahan
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-09-10       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.